You are currently browsing the tag archive for the ‘FDA’ tag.

( – During Tuesday’s second  presidential debate, President Barack Obama said that  women “rely” on Planned Parenthood for mammograms, but, according to the Food and Drug Administration, no Planned Parenthood facility in the United States is licensed to do mammograms.

During Tuesday night’s debate against his Republican challenger Mitt  Romney, Obama said, “When Gov. Romney says that we should eliminate  funding for Planned Parenthood, there are millions of women all across  the country who rely on Planned Parenthood for not just contraceptive  care; they rely on it for mammograms, for cervical cancer screenings.  That’s a pocketbook issue for women and families all across the country,  and it makes a difference in terms.


But, give Sharfstein some credit. He has superb political instincts and understands precisely when it is time to go. Just after the new Chairman of the House Oversight Committee, Darrel Issa, announced that he intended to call hearings to examine some of the dodgy decisions at the FDA, Josh Sharfstein headed for the door. Could be a coincidence, or maybe there was no way he could justify the strange and often disastrous decision-making at the FDA that has so badly compromised a once-proud agency. Better by far, Sharfstein seems to have decided, to slip out the back door and let someone else take the heat for all the misdeeds.

Ironically, Sharfstein has now accepted a top public health job in the State of Maryland where he will be forced to deal with a huge number of small biotech companies working on a number of novel medical breakthroughs, but face impending insolvency because of an inability to navigate the increasingly complex myriad regulatory gauntlet at the FDA that has been erected. Good luck with that. Most likely, Sharfstein will get an earful, and, perhaps for the first time, learn the painful truth about the full costs of his misguided policies.

For full article:

The action on all these fronts in the days before the 112th Congress opens shows that oversight has suddenly become a hot topic in Washington, and it’s forcing the White House, House Democrats and the influence industry to take notice.

Republicans have begun to lay out their hearing schedule, which will include investigations into how regulation affects job creation; inquiries into Fannie Mae, Freddie Mac and the foreclosure crisis; and an examination of the Financial Crisis Inquiry Commission’s failure to come to agreement on the cause of the crisis. Issa also wants to investigate WikiLeaks disclosures.
Read more:

“Authorities in the UK should be on the alert because its sister vaccine, Gardasil, used in America , has already been associated with 32 deaths, she said.

Her comments follow the death of 14-year-old Natalie Morton, who collapsed an hour after receiving the jab at school last week.

It is highly unusual for a researcher to  publicly criticise a vaccine which they helped get approved.”

Note: If the US Government was so sure of the benefit and effectiveness of the H1N1 vaccine that is about to be released, why have they made the manufacturers immune from any litigation as a result of this particular drug?